Nivolumab-induced immune-related neutropenia in a renal cell carcinoma patient.

Ender Kalaci Yuksel Urun

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)

IrN associated with nivolumab treatment for metastatic ccRCC is uncommon. The pathophysiology of irN is not entirely understood. Corticosteroids are one of the most commonly used drugs for the treatment of irN. As ICIs become more widely used, medical oncologists will encounter this side effect more frequently.

Keyphrases

renal cell carcinoma
squamous cell carcinoma
case report
drug induced
palliative care
replacement therapy